Based on these reports, to predict the development of HCC in patients with chronic liver disease, we previously established a new scoring system, VFMAP, based on older age, male sex, liver fibrosis (VTQ), high AFP level, and fasting hyperglycemia. This evidence concerns the gene AFP and Hyperglycemia.